CORRESP Filing
60 DEGREES PHARMACEUTICALS, INC.
Date: July 10, 2025 · CIK: 0001946563 · Accession: 0001213900-25-062836
AI Filing Summary & Sentiment
File numbers found in text: 333-288550
Show Raw Text
CORRESP
1
filename1.htm
July 10, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation
Finance
100 F Street
NE Washington, D.C. 20549
Re:
60 Degrees Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-288550
Ladies and Gentlemen:
In accordance
with Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), H.C. Wainwright & Co., LLC ("Wainwright"),
as placement agent on a best-efforts basis, hereby joins 60 Degrees Pharmaceuticals, Inc. in requesting that the Securities and Exchange
Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-288550) (the "Registration Statement")
to become effective on Monday, July 14, 2025, at 5:15 p.m., Eastern Time, or as soon as practicable thereafter. Wainwright affirms that
it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
[Signature Page Follows]
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
Name:
Edward D. Silvera
Title:
Chief Operating Officer
[Signature Page to Acceleration Request]